The table below shows FENNEC PHARMACEUTICALS INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$12.47M
$26.98M
-$17.14M
-$18.06M
-$14.22M
-$15.60M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-
-
-
-
-
-
Dividends paid
-
-
-
-
-
-
FENC operating cash flow (10-K history)
FENNEC PHARMACEUTICALS INC. reported operating cash flow of -$12.47M for fiscal year 2025. That is down 146.2% from $26.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$2.12M (FY 2016) to -$12.47M. Figures come from the company's audited annual reports as filed with the SEC.